OpenAI Seeks Legal Cover for Industry-Wide AI Development Pause
OpenAI has queried Congress about whether competitors can legally coordinate a slowdown in frontier AI development without violating antitrust law. The tension between safety goals and competition rules leaves companies uncertain whether collective action is permitted.

There is growing consensus among frontier AI developers that the pace of capability advancement should decelerate. However, a fundamental legal barrier complicates this goal: whether such a slowdown can be pursued collectively without running afoul of antitrust enforcement.
According to WIRED's reporting, OpenAI has contacted congressional representatives to explore whether an industry-coordinated pause on frontier AI model development would constitute an antitrust violation. The question highlights a paradox in competition law: a company acting alone can reduce its own development speed without legal consequence, but when multiple competitors reach similar agreements, federal authorities may intervene.
The Sherman Antitrust Act treats formal agreements among rivals to restrict output or delay product launches as potentially illegal. A single laboratory can independently choose to slow or halt its work, yet coordinated commitments between competing organizations trigger regulatory concern, even when the stated rationale centers on safety.
This legal ambiguity itself may discourage collaborative safety efforts. Nicholas Felstead, an assistant director at the Australian Competition and Consumer Commission, noted in a March paper that "legal uncertainty can act as a powerful deterrent," according to WIRED's account of coordinated AI pauses.
Congress has proposed one potential remedy: the bipartisan Collaboration on Adversarial Threats and Security Risks Act, backed by Sens. Adam Schiff and Jim Banks. This legislation would create a framework allowing safety collaborations provided companies notify the Department of Justice in advance. Yet the bill remains stalled in the House Judiciary Committee, offering no immediate legal protection as midterm elections approach.
Public agreement masks underlying divisions
Recent weeks have brought unusual public consensus from major AI leaders on the need for restraint. Anthropic CEO Dario Amodei stated publicly that companies should "slow the pace at which we improve the capabilities of AI models." OpenAI CEO Sam Altman responded on X with support: "I agree with Dario that we need to pace the frontier." Elon Musk, leading xAI, added his backing, writing, "Dario is right."
Skepticism, however, remains substantial within both industry and political circles. Rep. Josh Gottheimer, D-N.J., rejected the self-regulation proposals as insufficient. "If Dario and Elon are truly worried, they can pump the brakes at their own labs, today," Gottheimer told POLITICO.
John Schulman, an OpenAI co-founder now serving as chief scientist at Thinking Machines, contended that antitrust concerns are being misused as cover for corporate inaction. "They'll cite antitrust, but that's fake—antitrust prohibits certain agreements, but not from jointly developing a proposal," Schulman wrote on X.
The risk of market entrenchment
By seeking Washington's guidance on permissible coordination, frontier labs are potentially diverting focus from individual responsibility. If established leaders obtain government authorization for a market-wide pause mechanism, they could consolidate a dominant position: incumbents maintain their market standing at current capability levels while emerging competitors encounter regulatory obstacles to advancing beyond those thresholds.
Expanding the legal latitude for joint decisions on slowing certain AI development categories could mitigate antitrust concerns around collective safety initiatives. Simultaneously, policymakers must ensure such arrangements do not function as protective walls shielding dominant firms from newer entrants seeking to innovate faster.
This balancing act sits at the core of OpenAI's congressional inquiry. Insufficient coordination may leave organizations hesitant to address mutual risks. Excessive legal protection, conversely, could grant the largest research labs outsized control over industry advancement rates.
For organizations deploying cutting-edge AI systems, any sector-level restraint remains speculative at this stage. Enterprises must prepare for the likelihood that frontier models will advance at accelerating rates and establish their own safeguards governing how these technologies are implemented.
In related developments, President Donald Trump downplayed concerns that AI poses existential risks to humanity, stating instead that his primary focus is maintaining U.S. technological superiority over China as competition in advanced systems intensifies.

